Loading Events

« All Events

  • This event has passed.

Deadline for NIAID BAA Proposals: Therapeutic Products for Biodefense, AMR Infections, and Emerging Infectious Diseases

April 9, 2020


Research Area 004: Development of Therapeutic Products for Biodefense, Anti-Microbial Resistant (AMR) Infections, and Emerging Infectious Diseases

Supports development of promising new therapeutics to address infections caused by NIAID Category A, B, and C priority pathogens and select bacterial and fungal infections identified in CDC’s report Antibiotic Resistance Threats in the United States 2019 , including optimization, preclinical (investigational new drug-enabling), and clinical trials that include Phase I and Phase II studies.

Due Date: April 9, 2020, by 3 p.m. Eastern Time

Read more on this opportunity in Funding News.


Global Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.


Global Biodefense Calendar
View Venue Website


National Institute of Allergy and Infectious Diseases (NIAID)
View Organizer Website